Cargando…

Gastrointestinal and genitourinary toxicity profiles of metformin versus placebo in men with prostate cancer receiving prostate radiotherapy: interim toxicity results of a double-blinded, multicenter, phase II randomized controlled trial

Androgen deprivation therapy (ADT) used for prostate cancer (PCa) management is associated with metabolic and anthropometric toxicity. Metformin given concurrent to ADT is hypothesized to counteract these changes. This planned interim analysis reports the gastrointestinal and genitourinary toxicity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Julian O., McDonald, Megan O., Ong, Aldrich, Koul, Rashmi, Dubey, Arbind, Hunter, William, Ahmed, Shahida, Quon, Harvey, Yee, Don, Parliament, Matthew, Sivananthan, Gokulan, Danielson, Brita, Rowe, Lindsay, Ghosh, Sunita, Usmani, Nawaid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567697/ https://www.ncbi.nlm.nih.gov/pubmed/34736499 http://dx.doi.org/10.1186/s13014-021-01935-x

Ejemplares similares

Factors Associated with Long-Term Prostate Cancer Survival after Palliative Radiotherapy to a Bone Metastasis and Contemporary Palliative Systemic Therapy: A Retrospective, Population-Based Study
por: Venugopal, Bindu, et al.
Publicado: (2023)

Bracing for impact with new 4R’s in the COVID-19 pandemic – A provincial thoracic radiation oncology consensus()
por: Rathod, Shrinivas, et al.
Publicado: (2020)

Cone-beam CT delta-radiomics to predict genitourinary toxicities and international prostate symptom of prostate cancer patients: a pilot study
por: Delgadillo, Rodrigo, et al.
Publicado: (2022)

Patient-reported genitourinary toxicity for long-term prostate cancer survivors treated with radiation therapy
por: Olsson, C E, et al.
Publicado: (2013)

Periodical assessment of genitourinary and gastrointestinal toxicity in patients who underwent prostate low-dose-rate brachytherapy
por: Tanaka, Nobumichi, et al.
Publicado: (2013)

Seminal Vesicle Treatment for Localized Prostate Cancer Treated with External Beam Radiotherapy
por: Steed, Tanner, et al.
Publicado: (2023)

Long term genitourinary toxicity following curative intent intensity-modulated radiotherapy for prostate cancer: a systematic review and meta-analysis
por: David, Rowan, et al.
Publicado: (2022)

Distinguishing prostate-specific antigen bounces from biochemical failure after low-dose-rate prostate brachytherapy
por: Hackett, Cian, et al.
Publicado: (2014)

Predictors for late genitourinary toxicity in men receiving radiotherapy for high-risk prostate cancer using planned and accumulated dose
por: Li Kuan Ong, Ashley, et al.
Publicado: (2023)

Body mass index can affect gastrointestinal and genitourinary toxicity in patients with prostate cancer treated with external beam radiation therapy
por: DOI, HIROSHI, et al.
Publicado: (2014)

Relationship between changes in quality of life and genitourinary toxicity grade after brachytherapy with I-125 alone for localised prostate cancer
por: Hashimoto, Yaichiro, et al.
Publicado: (2023)

Targeting the Tumor: Assessing the Impact of Bladder Volume and Position on Accuracy of Radiation Delivery for Patients with Bladder Cancer
por: Kochan, Andrew, et al.
Publicado: (2017)

Long-Term (10-Year) Gastrointestinal and Genitourinary Toxicity after Treatment with External Beam Radiotherapy, Radical Prostatectomy, or Brachytherapy for Prostate Cancer
por: Hunter, Grant K., et al.
Publicado: (2012)

Development and Validation of a Comprehensive Multivariate Dosimetric Model for Predicting Late Genitourinary Toxicity Following Prostate Cancer Stereotactic Body Radiotherapy
por: Valle, Luca F., et al.
Publicado: (2020)

Mechanism and Management of Checkpoint Inhibitor-Related Toxicities in Genitourinary Cancers
por: Li, Haoran, et al.
Publicado: (2022)

Overall Quality of Life Assessment in the Patients Undergoing External Beam Radiation in Outpatient Radiation Oncology Department
por: Koul, Rashmi, et al.
Publicado: (2015)

A Call for a Radiation Oncology Model Based on New 4R’s During the COVID-19 Pandemic
por: Rathod, Shrinivas, et al.
Publicado: (2020)

Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy
por: Kerns, Sarah L, et al.
Publicado: (2019)

Incidence of genitourinary complications following radiation therapy for localised prostate cancer
por: David, Rowan V., et al.
Publicado: (2022)

Comparison of chronic gastrointestinal and genitourinary toxicities between brachytherapy and external beam radiotherapy for patients with prostate cancer: A systematic review and meta-analysis
por: Li, Xuanzhe, et al.
Publicado: (2023)

Expectant management in genitourinary malignancies (prostate, bladder, kidney)
por: Van Hemelrijck, Mieke, et al.
Publicado: (2021)

The priority toxicant reference range study: interim report.
por: Needham, L L, et al.
Publicado: (1995)

Acute gastrointestinal and genitourinary toxicity of image-guided intensity modulated radiation therapy for prostate cancer using a daily water-filled endorectal balloon
por: Deville, Curtiland, et al.
Publicado: (2012)

Hypofractionated helical tomotherapy (75 Gy at 2.5 Gy per fraction) for localized prostate cancer: long-term analysis of gastrointestinal and genitourinary toxicity
por: Kong, Moonkyoo, et al.
Publicado: (2014)

Predicting post-radiation genitourinary hospital admissions in patients with localised prostate cancer
por: David, Rowan, et al.
Publicado: (2022)

Towards understanding the breast cancer epigenome: a comparison of genome-wide DNA methylation and gene expression data
por: Singhal, Sandeep K., et al.
Publicado: (2015)

Prostate cancer aggressiveness and financial toxicity among prostate cancer patients
por: KC, Madhav, et al.
Publicado: (2022)

Microbiota of Urine, Glans and Prostate Biopsies in Patients with Prostate Cancer Reveals a Dysbiosis in the Genitourinary System
por: Gonçalves, Micael F. M., et al.
Publicado: (2023)

Commentary on genitourinary cancer survivorship: physical activity and prostate cancer survivorship
por: Lavien, Garjae, et al.
Publicado: (2016)

Update on Circulating Tumor Cells in Genitourinary Tumors with Focus on Prostate Cancer
por: Cimadamore, Alessia, et al.
Publicado: (2020)

Key Role of Obesity in Genitourinary Tumors with Emphasis on Urothelial and Prostate Cancers
por: Santoni, Matteo, et al.
Publicado: (2019)

Adenoid cystic carcinoma of the prostate – A rare case of genitourinary malignancy
por: Ryan, Paul, et al.
Publicado: (2022)

A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients
por: Norkus, Darius, et al.
Publicado: (2013)

Unexpected Seed Migration in Prostate Brachytherapy Implants Coincident with Change in Seed Stranding Product
por: Rose, Jim, et al.
Publicado: (2017)

Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities
por: Xiao, Canhua, et al.
Publicado: (2018)

The Association between Acute and Late Genitourinary and Gastrointestinal Toxicities: An Analysis of the PACE B Study
por: Ratnakumaran, Ragu, et al.
Publicado: (2023)

Biological-effective versus conventional dose volume histograms correlated with late genitourinary and gastrointestinal toxicity after external beam radiotherapy for prostate cancer: a matched pair analysis
por: Jani, Ashesh B, et al.
Publicado: (2003)

31: Single Fraction Peripheral Lung SBRT During the Global COVID-19 Pandemic at a Cancercare Manitoba: An Analysis of Technical Feasibility and Clinical Safety
por: Alfaifi, Salem, et al.
Publicado: (2022)

(11)C-Choline PET Guided Salvage Radiation Therapy for Isolated Pelvic and Paraortic Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Rationale and Early Genitourinary or Gastrointestinal Toxicities
por: Jethwa, Krishan R., et al.
Publicado: (2019)

Stereotactic body radiation therapy for prostate cancer: a study comparing 3-year genitourinary toxicity between CyberKnife and volumetric-modulated arc therapy by propensity score analysis
por: Ito, Makoto, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9abg8u4ec4e1p3reb5ui8flilm